US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

54.80

+1.082.00%

Volume:983.71K

Turnover:53.80M

Market Cap:134.14B

PE:20.10

High:55.10

Open:55.02

Low:54.32

Close:53.72

Loading ...

Overview Company News Filings

Teva Shares Soar on Early Bowel Disease Drug Data -- Barrons.com

Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?

Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease

MT Newswires Live

Pre-Bell｜U.S. Futures Dip; Tesla Gains 2%; Nvidia Drops 2%; Palantir Sinks 3%; Quantum Stocks Shine

Tiger Newspress

Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial

Teva, Sanofi Say Drug to Treat IBD Met Primary Targets

SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS

Regeneron Down 15.5% Year to Date: How to Play the Stock?

Novavax Hits First Milestone in Sanofi Partnership, Secures $50 Million Payment

MT Newswires Live

Gilead Sciences Names Dietmar Berger as Chief Medical Officer

MT Newswires Live

NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines

Sanofi : Jefferies Cuts Target Price to $63.5 From $66.5

THOMSON REUTERS

Sanofi says Sarclisa combos showed benefits in multiple myeloma patients

Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?

Denali Starts Dosing in Phase II Parkinson's Disease Study

Press Release: Availability of the revised financial statements for Sanofi excluding Opella

Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M

Berenberg Bank Remains a Buy on Sanofi (SNY)

Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China

Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNY/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"Sanofi SA","latestPrice":54.795,"timestamp":1746036113841,"preClose":53.72,"halted":0,"volume":983709,"delay":0,"floatShares":2205948514,"shares":2448069980,"eps":2.726027,"marketStatus":"Trading","change":1.075,"latestTime":"04-30 14:02:05 EDT","open":55.02,"high":55.1,"low":54.32,"amount":53796619.383606,"amplitude":0.01452,"askPrice":54.8,"askSize":414,"bidPrice":54.79,"bidSize":195,"shortable":3,"etf":0,"ttmEps":2.726027,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":53.72,"dividendRate":0.037175,"preHourTrading":{"tag":"盘前","latestPrice":55.06,"preClose":53.72,"latestTime":"09:28 EDT","volume":1805,"amount":99262.88123,"timestamp":1746019680041},"postHourTrading":{"tag":"盘后","latestPrice":54.03,"preClose":53.72,"latestTime":"18:33 EDT","volume":2182,"amount":117289.18,"timestamp":1745965988396},"volumeRatio":0.418005,"impliedVol":0.279,"impliedVolPercentile":0.516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","floatShares":2205948514,"roa":"4.28%","roe":"7.30%","lyrEps":2.29994,"volumeRatio":0.418005,"shares":2448069980,"dividePrice":2.037,"high":55.1,"amplitude":0.01452,"preClose":53.72,"low":54.32,"week52Low":45.8,"pbRate":"1.52","psRate":"2.62","week52High":60.115,"institutionHeld":0.0837,"latestPrice":54.795,"committee":-0.359606,"eps":2.726027,"divideRate":0.037175,"volume":983709,"delay":0,"ttmEps":2.726027,"open":55.02,"prevYearClose":48.23,"prevWeekClose":52.32,"prevMonthClose":55.46,"prevQuarterClose":55.46,"fiveDayClose":53.02,"twentyDayClose":54.34,"sixtyDayClose":53.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNY\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2492968641","title":"Teva Shares Soar on Early Bowel Disease Drug Data -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2492968641","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492968641?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:17","pubTimestamp":1734445020,"startTime":"0","endTime":"0","summary":"Shares of drugmaker Teva Pharmaceutical Industries were up more than 20% in premarket trading Tuesday on the back of promising early data on a treatment for two chronic bowel conditions.Teva and its partner Sanofi said that 47.8% of patients with ulcerative colitis who received a high dose of their drug duvakitug experienced clinical remission, compared with 20.5% who received a placebo.The results were similar for patients with Crohn's disease. The companies said that both responses were significant and clinically meaningful.Teva's American depositary receipts were up 20% in premarket trading, while ADRs of Sanofi, the far larger of the two partners, were up 4.1%.Crohn's disease and ulcerative colitis are both chronic inflammatory conditions impacting the colon. While there are a number of medicines on the market to treat the diseases, Teva called duvakitug \"potentially best-in-class\" in a presentation on Tuesday morning.\"These positive results reinforce Teva's ability to develop and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY","BK4588","IE00BFXG1179.USD","TEVA","BK4584","BK4007","BK4566","BK4557","BK4559","BK4585","BK4596"],"gpt_icon":0},{"id":"2492963561","title":"Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2492963561","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492963561?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:16","pubTimestamp":1734444992,"startTime":"0","endTime":"0","summary":"On Tuesday, Teva Pharmaceutical Industries Ltd.  and Sanofi SA’s  Phase 2b RELIEVE UCCD study met its primary endpoints in patients with ulcerative colitis  and Crohn’s disease .RELIEVE UCCD investigated duvakitug , a human IgG1-λ2 monoclonal antibody targeting TL1A, for moderate-to-severe inflammatory bowel disease .In the RELIEVE UCCD study, 36.2%  and 47.8%  of patients with ulcerative colitis treated with duvakitug achieved clinical remission compared to 20.45% on placebo, placebo-adjusted rates were 15.7%  and 27.4% , at week 14.Also Read: Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug. Overall, the treatment effect was consistent across subgroups.Duvakitug was generally well tolerated in ulcerative colitis and Crohn’s disease, with no safety signal identified.Ulcerative colitis and Crohn’s disease, the two main types of IBD, are chronic inflammatory conditions of the GI tract resulting in symptoms such as abd","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/KjRbkKbKpeJEOpjN7kNeqA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/bb5745124c89d78e3ebe1a750f38aa02","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/KjRbkKbKpeJEOpjN7kNeqA--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/bb5745124c89d78e3ebe1a750f38aa02"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-teva-sanofi-stocks-trading-141632272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNY","BK4007","BK4557","CD","IE00BFXG1179.USD","BK4559","TEVA","BK4596","BK4585","SNYNF","BK4116","BK4138","BK4588","BK4584","IBD","BK4566","AE"],"gpt_icon":0},{"id":"2492957101","title":"Teva, Sanofi Say Phase 2B Duvakitug Study Meets Primary Endpoints in Inflammatory Bowel Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2492957101","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492957101?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:43","pubTimestamp":1734442998,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  US affiliate Teva Pharmaceuticals and Sanofi  said Tuesday that a phase 2b study on duvakitug met primary endpoints in patients with ulcerative colitis and Crohn's disease, the most common forms of inflammatory bowel disease.The companies said 47.8% of ulcerative colitis patients treated with high-dose duvakitug achieved clinical remission at week 14 and 47.8% of Crohn's disease patients on high-dose duvakitug achieved endoscopic response.Duvakitug was well tolerated, with adverse event rates similar between treatment and placebo groups, the companies added.Teva and Sanofi said they plan to initiate a phase 3 trial after regulatory discussions. Detailed results of the phase 2b trial are expected to be presented in 2025, they added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNY","BK4588","IE00BFXG1179.USD","TEVA","BK4584","BK4007","BK4566","BK4557","BK4559","BK4585","SNYNF","BK4596"],"gpt_icon":0},{"id":"1163081867","title":"Pre-Bell｜U.S. Futures Dip; Tesla Gains 2%; Nvidia Drops 2%; Palantir Sinks 3%; Quantum Stocks Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=1163081867","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163081867?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:43","pubTimestamp":1734442980,"startTime":"0","endTime":"0","summary":"U.S. stock index futures dipped on Tuesday, with rising bond yields adding pressure as traders braced for retail sales data that will provide more clues on the health of consumers ahead of an anticipa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3b1e74be79ddbb8b0eefa5ab5c7ba16b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDA","SNY",".SPX","TEVA","PFE","ESmain","QUBT","QBTS","AFRM","TSLA","YMmain","NQmain","AVGO","NET","QMCO","EVGO","RCAT","AMTM","NUE","SEDG","PLTR",".IXIC","RGTI",".DJI"],"gpt_icon":1},{"id":"2492195222","title":"Teva, Sanofi Say IBD Treatment Achieved Higher Remission at Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2492195222","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492195222?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":"Teva Pharmaceuticals and Sanofi report that the latest trial of their jointly developed treatment for inflammatory bowel disease met its primary endpoints.The companies said Tuesday that patients with ulcerative colitis who were treated with duvakitug achieved a higher rate of clinical remission compared with a placebo group. A group of patients with Crohn's disease who were treated with duvakitug achieved a higher rate of remission than those treated with a placebo.The treatment effect was consistent across subgroups, the companies said.Teva's shares surged 18% to $19.53 in premarket trading. Sanofi's American depositary receipts were up 3.7% at $47.57.Duvakitug was generally well tolerated across both patient groups and showed similar rates of treatment-emergent adverse events.\"I am deeply moved by the potential for duvakitug to help treat and meaningfully improve the quality of life of people living with IBD,\" Hughes said.Teva and Sanofi said in November 2023 that they had closed a ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4596","SNY","IBD","SNYNF","TEVA","BK4585","IE00BFXG1179.USD","BK4007","BK4557","BK4559","BK4588","BK4566"],"gpt_icon":0},{"id":"2492959530","title":"Teva, Sanofi Say Drug to Treat IBD Met Primary Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2492959530","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492959530?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:10","pubTimestamp":1734441000,"startTime":"0","endTime":"0","summary":"Teva, Sanofi say drug to treat IBD met primary targetsBy Steven Scheer","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL8N3NI0PE:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Teva, Sanofi Say Drug to Treat IBD Met Primary Targets","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA","SNY"],"gpt_icon":1},{"id":"2491305286","title":"SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS","url":"https://stock-news.laohu8.com/highlight/detail?id=2491305286","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491305286?lang=en_us&edition=fundamental","pubTime":"2024-12-13 23:58","pubTimestamp":1734105480,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its investigational oral BTK inhibitor, tolebrutinib, for treating adults with non-relapsing secondary progressive multiple sclerosis .The FDA grants breakthrough therapy designation to expedite the development and review of therapies for severe or life-threatening diseases where preliminary clinical evidence shows that the therapy may provide substantial improvements over available treatments.There are no approved therapies to treat nrSPMS at present. Multiple sclerosis  is a chronic neurodegenerative disease that causes disability accumulation over time, which is not properly addressed by the currently available therapies, and there remains a significant unmet need for MS treatment.Year to date, shares of Sanofi have declined 5.5% against the industry’s increase of 7.4%.Breakthrough Therapy Tag Based on Data From SNY's HERCULES Study. The FDA’s Breakthrough Therapy designation for tolebrutinib was bas","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MPLv._QOfr9ekgf5qyZbUA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MPLv._QOfr9ekgf5qyZbUA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4c89fa4c828d913dc49739912177a966"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/snys-tolebrutinib-gets-fda-breakthrough-155800256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","BK4223","BK4534","LU1363072403.SGD","CDP","CSTL","LU2089283258.USD","BK4516","BK4581","LU2357305700.SGD","IE0031619046.USD","LU1720051108.HKD","BK4585","LU2028103732.USD","LU0158827948.USD","LU1548497426.USD","BK4123","IE00B66KJ199.SGD","BK4504","IE00BZ1G4Q59.USD","LU0006306889.USD","SPRO","IE00B7SZL793.SGD","LU0225283273.USD","LU1989772840.SGD","BK4139","LU1162221912.USD","IE00BFXG1179.USD","LU0320765646.SGD","BK4007","LU0971096721.USD","LU1989772923.USD","IE00B19Z4B17.USD","LU0098860793.USD","LU0106831901.USD","LU2271345857.HKD","LU0158827781.USD","BK4127","SNY","CTMX","BK4588","MG","IE00BKVL7J92.USD","LU1720051017.SGD","LU0314104364.USD","LU2089284900.SGD","LU0267386448.USD","LU0106261372.USD","LU1074936037.SGD","LU2111349929.HKD"],"gpt_icon":0},{"id":"2491537198","title":"Regeneron Down 15.5% Year to Date: How to Play the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2491537198","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491537198?lang=en_us&edition=fundamental","pubTime":"2024-12-13 22:09","pubTimestamp":1734098940,"startTime":"0","endTime":"0","summary":"Shares of Regeneron Pharmaceuticals, Inc. REGN have dropped 15.5% in the year so far compared with the industry’s decline of 6.3%.The stock has underperformed the sector and the S&P 500 Index during this timeframe. While the stock’s performance was encouraging at the onset of 2024, challenges for lead drug Eylea have dampened investors’ sentiment of late.Eylea is an anti-vascular endothelial growth factor inhibitor approved for various ophthalmology indications.Regeneron has a collaboration agreement with Bayer BAYRY for Eylea. Regeneron records the net product sales of Eylea and Eylea HD in the United States, and Bayer records its net product sales outside the country. Regeneron records its share of profits in connection with Eylea’s sales outside the United States.REGN’s oncology franchise got a boost with the European Commission's approval of odronextamab for treating adult patients with relapsed or refractory (R/R) follicular lymphoma  or R/R diffuse large B-cell lymphoma after two","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0.VF5p.GUKhgU24gMni2XA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0.VF5p.GUKhgU24gMni2XA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59a827b8514d5d6d47690daa5eb16f24"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/regeneron-down-15-5-date-140900718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765992.SGD","LU0823416689.USD","LU2362541513.USD","BK4588","03165","LU0109394709.USD","BK4139","LU2362540622.SGD","LU0114720955.EUR","REGN","LU1974910355.USD","LU2362541273.HKD","LU0053666078.USD","LU2106854487.HKD","LU0058720904.USD","LU0882574055.USD","IE00BFXG1179.USD","BK4585","BK4530","LU0289739699.SGD","LU0390134368.USD","BK4094","LU0889565916.HKD","LU2023250504.SGD","LU2089984988.USD","LU2468319806.SGD","BK4121","BAYRY","RHHBY","FL","SNY","CRL","BK4007","LU1917777945.USD"],"gpt_icon":0},{"id":"2491270753","title":"Novavax Hits First Milestone in Sanofi Partnership, Secures $50 Million Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2491270753","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491270753?lang=en_us&edition=fundamental","pubTime":"2024-12-13 21:29","pubTimestamp":1734096588,"startTime":"0","endTime":"0","summary":"Novavax  said Friday it achieved the first milestone under its agreement with Sanofi , earning a $50 million payment tied to progress in its phase 2/3 trial for a COVID-19 vaccine in children.The payment marks the first milestone since the partnership began in May, Novavax said. The company could earn up to $300 million in additional milestones related to its COVID-19 vaccine and a further $350 million for combination products under the agreement, alongside tiered royalties on future sales.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4547","NVAX","BNTX","BK4568","IE00BFXG1179.USD","BK4139","BK4551","BK4007","BK4585","BK4535","BK4548","BK4588","SNY","SNYNF"],"gpt_icon":1},{"id":"2491365886","title":"Gilead Sciences Names Dietmar Berger as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2491365886","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491365886?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:53","pubTimestamp":1734044021,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said it appointed Dietmar Berger as its chief medical officer, effective Jan. 2, replacing Merdad Parsey.Berger brings over 25 years of experience in \"developing and delivering innovative medicines across a broad range of therapeutic areas,\" Gilead said late Thursday. He will also join Gilead's senior leadership team.Most recently, Berger was the CMO at Sanofi .","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4583","LU0320765992.SGD","IE00B19Z3581.USD","BK4588","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU0109394709.USD","BK4139","BK4578","BK4566","IE0002270589.USD","IE00B19Z3B42.SGD","BK4550","LU0234570918.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1571399168.USD","LU0058720904.USD","IE00BSNM7G36.USD","IE00BFXG1179.USD","BK4585","LU1839511570.USD","BK4532","LU0289739699.SGD","LU0889565916.HKD","GILD","IE00B3T34201.USD","LU2468319806.SGD","LU1585245621.USD","BK4568","LU1430594728.SGD","SNY","BK4007","LU1066053197.SGD"],"gpt_icon":0},{"id":"2490868314","title":"NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868314","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490868314?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:50","pubTimestamp":1733921400,"startTime":"0","endTime":"0","summary":"Novavax NVAX announced that it has started dosing participants in the phase III study evaluating its experimental COVID-19-influenza combination  and stand-alone influenza vaccine candidates.The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s currently authorized COVID-19 vaccine and a licensed seasonal influenza vaccine. Management will also assess the immunogenicity and safety of its standalone influenza vaccine.Both experimental vaccines will utilize the company’s proprietary adjuvant technology, Matrix-M, to enhance the immune response. The study will focus on adults aged 65 and older.NVAX is also exploring strategic collaborations to finance the late-stage development and potential commercialization of both candidates.This initiation is supported by data from a mid-stage study, which showed that both vaccines were well-tolerated and generated robust immune responses when compared with authorized comparators like Novava","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/41D0IKqXpOevA73jRCvjig--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ef34b229359328ddb52bd15cfa3b6b2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/41D0IKqXpOevA73jRCvjig--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ef34b229359328ddb52bd15cfa3b6b2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvax-starts-stage-study-covid-125000553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","IE00B19Z3B42.SGD","LU0122379950.USD","BK4585","BK4533","IE00BLSP4452.SGD","LU0234572021.USD","SG9999001176.USD","LU0170899867.USD","BK4550","BK4501","IE000M9KFDE8.USD","NVAX","LU0456855351.SGD","SG9999011175.SGD","BK4551","BNTX","LU1066053197.SGD","BK4139","IE00B19Z3581.USD","LU1066051498.USD","LU0306806265.USD","SSI","BK4532","SG9999002232.USD","LU1023059063.AUD","BK4534","BK4592","LU0225771236.USD","SGXZ57979304.SGD","MRNA","SG9999003800.SGD","BK4547","IE00BLSP4239.USD","BK4599","BK4581","LU0225284248.USD","SG9999001176.SGD","LU0058720904.USD","LU1894683348.USD","PFE","LU0306807586.USD","LU0321505868.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0868494617.USD","IE0002270589.USD","SNY","LU0289739699.SGD","LU1894683264.USD"],"gpt_icon":1},{"id":"2490653220","title":"Sanofi : Jefferies Cuts Target Price to $63.5 From $66.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2490653220","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490653220?lang=en_us&edition=fundamental","pubTime":"2024-12-10 15:47","pubTimestamp":1733816843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nFWN3NB0PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFXG1179.USD","BK4588","BK4007","SNY","BK4585"],"gpt_icon":0},{"id":"2490704898","title":"Sanofi says Sarclisa combos showed benefits in multiple myeloma patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2490704898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490704898?lang=en_us&edition=fundamental","pubTime":"2024-12-10 03:15","pubTimestamp":1733771711,"startTime":"0","endTime":"0","summary":"Sanofi (SNY) says new data from three oral presentations demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly diagnos...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sanofi-says-sarclisa-combos-showed-benefits-in-multiple-myeloma-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sanofi-says-sarclisa-combos-showed-benefits-in-multiple-myeloma-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFXG1179.USD","BK4585","BK4588","SNY","BK4007"],"gpt_icon":0},{"id":"2489725163","title":"Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2489725163","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489725163?lang=en_us&edition=fundamental","pubTime":"2024-12-07 00:31","pubTimestamp":1733502676,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for Denali Therapeutics Inc. . Shares have lost about 21.2% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Denali Therapeutics due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging. Denali incurred a third-quarter 2024 loss of 63 cents per share, wider than the Zacks Consensus Estimate of a loss of 60 cents. The company reported a loss of 72 cents in the year-ago quarter.The bottom line improved year over year despite a rise in operating expenses, mainly due to an increase in the number of shares outstanding.In the absence of a marketed product, the company only recognizes revenues from ongoing collaborations. Denali did not generate c","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/HIalcDlt7JZPKSITVlxPuw--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-denali-therapeutics-dnli-down-163116909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNY","AGIO","DNLI"],"gpt_icon":0},{"id":"2489237703","title":"Denali Starts Dosing in Phase II Parkinson's Disease Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2489237703","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489237703?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:48","pubTimestamp":1733496480,"startTime":"0","endTime":"0","summary":"Denali Therapeutics Inc. DNLI initiated dosing in a global mid-stage study, BEACON, on BIIB122 .BIIB122, an investigational drug leucine-rich repeat kinase 2  inhibitor, is being evaluated in participants with LRRK2-associated Parkinson’s disease .Shares of DNLI have risen 8.7% year to date against the industry’s 8.4% decline.The phase IIa study will evaluate safety and biomarkers associated with oral daily dosing of BIIB122 in approximately 50 participants with Parkinson’s disease and LRRK2 pathogenic mutations confirmed by genetic testing.In September, Denali announced that its meeting with the FDA's Center for Drug Evaluation and Research  division to advance DNL310 was successful.The meeting with CDER outlined a path for Denali to file a biologics license application  seeking accelerated approval of tividenofusp alfa  for the treatment of MPS II and its subsequent conversion to full approval.Denali agreed with the CDER that cerebrospinal fluid heparan sulfate  is reasonably likely ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/denali-starts-dosing-phase-ii-144800152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BIIB","BK4548","IE00B19Z9Z06.USD","BK4139","SNY","BK4535","SPRO","DNLI","BK4533","IE00B894F039.SGD","IE00B19Z9P08.USD","BK4007","LU0234570918.USD","IE00BFXG1179.USD","BK4532","ETV","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","BK4588"],"gpt_icon":1},{"id":"2489403418","title":"Press Release: Availability of the revised financial statements for Sanofi excluding Opella","url":"https://stock-news.laohu8.com/highlight/detail?id=2489403418","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489403418?lang=en_us&edition=fundamental","pubTime":"2024-12-06 14:30","pubTimestamp":1733466600,"startTime":"0","endTime":"0","summary":"Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella  to CD&R, the revised financial statements for Sanofi reflecting the new scope, excluding Opella, are now available on the \"Investors\" section of sanofi.com in one convenient spreadsheet file.The adjustments to the financial statements reclassify Opella’s business as discontinued operations, in line with the planned transition of Sanofi to a focused, science-driven biopharma company.Forward-looking statementsThis press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assump","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OPTreMFV4QxkZ_hb1FVJzw--~B/aD0xNjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/9e521264632e7a9a44e3450108999128"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-availability-revised-financial-063000881.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFXG1179.USD","BK4588","SNY","BK4585","SNYNF","BK4007"],"gpt_icon":0},{"id":"2489499567","title":"Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M","url":"https://stock-news.laohu8.com/highlight/detail?id=2489499567","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489499567?lang=en_us&edition=fundamental","pubTime":"2024-12-06 00:54","pubTimestamp":1733417640,"startTime":"0","endTime":"0","summary":"Novavax NVAX announced that it has agreed to sell its manufacturing facility in the Czech Republic to pharma giant Novo Nordisk NVO for $200 million. The deal is expected to be closed before this year’s end.After completing this sale, Novo Nordisk will acquire a 150,000-square-foot recombinant protein manufacturing facility, along with its support buildings, existing workforce and all necessary infrastructure. In return, Novavax will receive $190 million in cash this year and the remaining $10 million next year.This Czech plant was initially acquired by Novavax in 2020 from the India-based Cyrus Poonawalla Group for $167 million. At the time, the acquisition was made to scale up the manufacturing output of its protein-based COVID-19 vaccine during the COVID-19 pandemic. However, those plans never came to fruition due to the vaccine’s delayed commercial launch.The deal bodes well for Novavax as it helped scrap a prior warning over the company’s ability to continue operations and provide","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/41D0IKqXpOevA73jRCvjig--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ef34b229359328ddb52bd15cfa3b6b2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/41D0IKqXpOevA73jRCvjig--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5ef34b229359328ddb52bd15cfa3b6b2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novavax-sell-czech-manufacturing-plant-165400470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVAX","IE00BZ1G4Q59.USD","NVO","IE00BFXG1179.USD","LU1093756325.SGD","LU0154236417.USD","SNY","BK4548","BK4547","BK4139","BK4585","BK4535","IE00BKVL7J92.USD","BK4532","BK4599","LU1093756168.USD","BNTX","BK4568","BK4551","BK4007","BK4588"],"gpt_icon":1},{"id":"2488084966","title":"Berenberg Bank Remains a Buy on Sanofi (SNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2488084966","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488084966?lang=en_us&edition=fundamental","pubTime":"2024-12-03 15:15","pubTimestamp":1733210137,"startTime":"0","endTime":"0","summary":"Berenberg Bank analyst Luisa Hector maintained a Buy rating on Sanofi (SNY – Research Report) yesterday and set a price target of $63.00. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/berenberg-bank-remains-a-buy-on-sanofi-sny?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/berenberg-bank-remains-a-buy-on-sanofi-sny?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFXG1179.USD","BK4585","BK4007","SNY","BK4588"],"gpt_icon":0},{"id":"2488956636","title":"Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2488956636","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488956636?lang=en_us&edition=fundamental","pubTime":"2024-12-03 13:35","pubTimestamp":1733204100,"startTime":"0","endTime":"0","summary":"Sanofi plans to spend about $1.05 billion building a new insulin manufacturing base in China, the French company's largest single investment in the world's second-largest economy.The French drugmaker said in a WeChat statement on Monday that the investment of about 1 billion euros, equivalent to $1.05 billion, will enhance the production and manufacturing of insulin, focusing on serving local diabetic patients. The new base, which will be located in Yizhuang, Beijing, marks Sanofi's second production base in the capital and its fourth in the country.Sanofi chairman Frédéric Oudéa in his first visit to China since taking on the role attended the contract signing ceremony in Beijing, together with Chief Executive Paul Hudson and a team of senior executives, the statement said.The Paris-based company has been in the Chinese market for over 40 years, where as of end-2021 there were over 140 million adults with diabetes, or about 12% of the population, according to the statement.U.S.-China ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BFXG1179.USD","SNY","BK4585","SNYNF","BK4007"],"gpt_icon":0},{"id":"2487559242","title":"Astrazeneca's Enhertu, Orpathys Among 91 Drugs Added to China's National Reimbursement Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=2487559242","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487559242?lang=en_us&edition=fundamental","pubTime":"2024-11-29 21:09","pubTimestamp":1732885789,"startTime":"0","endTime":"0","summary":"Astrazeneca  confirmed Friday in an emailed statement to MT Newswires that its breast cancer treatment Enhertu and cancer treatment Orpathys have been added to China's National Reimbursement Drug List The inclusion in the NRDL grants state-run medical insurance coverage to the cancer treatments, starting Jan. 1, 2025, multiple media outlets reported Thursday.Enhertu is among 91 drugs that will be added to the NRDL, including oncology drugs from drugmakers including Johnson & Johnson , Merck , Bristol Myers , Roche and Sanofi , Bloomberg said and added that drugmakers have to accept price cuts, averaging 63%, to secure inclusion on the list.Zai Lab  said Thursday its AUGTYRO was also included in the NRDL to treat adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1430594728.SGD","LU1868836757.USD","IE0009355771.USD","LU2462157665.USD","LU1585245621.USD","SNY","LU1974910355.USD","SG9999014575.USD","LU1116320737.USD","LU1868837136.USD","IE00B3PB1722.GBP","LU1732800096.USD","LU0321505868.SGD","LU0965509010.AUD","LU2242646821.SGD","LU1989772923.USD","IE00BLSP4452.SGD","LU2236285917.USD","LU0070302665.USD","AZN","LU1244550494.USD","ZLAB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","BMY","LU0208291251.USD","JNJ","IE00BN8TJ469.HKD","MRK","NHLD","LU1057294990.SGD","IE00B4R5TH58.HKD","SG9999013999.USD","LU1778281490.HKD","LU2106854487.HKD","LU1280957306.USD","SG9999002232.USD","BK4548","LU0320765646.SGD","LU1221951129.SGD","BGNE","LU1116320901.HKD","LU0320765992.SGD","LU1868836914.USD","LU1868837300.USD","BK4526","LU1093756325.SGD","LU1093756168.USD","LU0882574055.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNY\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"SNY","amount":2.212154,"announcedDate":"2025-04-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"赛诺菲安万特","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-06-12"},{"market":"US","date":"2025-04-24","symbol":"SNY","fiscalQuarterEnding":"2025/03","expectedEps":0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"pre","actualEps":0.94},{"market":"US","date":"2025-01-30","symbol":"SNY","fiscalQuarterEnding":"2024/12","expectedEps":0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.7},{"market":"US","date":"2024-10-25","symbol":"SNY","fiscalQuarterEnding":"2024/09","expectedEps":1.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1729828800000,"reportTimeType":"pre","actualEps":1.57},{"date":"2024-09-12","symbol":"SNY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1726128000000,"name":null,"time":"Pre-Market","dateTimestamp":1726113600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNY\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-06","recordDate":"2015-05-08","paymentDate":"2015-06-02","value":1.086507,"currency":"USD"},{"executeDate":"2016-05-05","recordDate":"2016-05-09","paymentDate":"2016-06-01","value":1.124297,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-06-07","value":1.053962,"currency":"USD"},{"executeDate":"2018-05-09","recordDate":"2018-05-10","paymentDate":"2018-06-04","value":1.252612,"currency":"USD"},{"executeDate":"2019-05-07","recordDate":"2019-05-08","paymentDate":"2019-05-31","value":1.739462,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.2857,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1742616000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNY","date":"2025-04-28","current":18.091389,"percent":0.55892,"low":7.700371,"twenty":10.042807,"median":17.659092,"eighty":24.157724,"high":35.240461,"avg":17.757772,"sd":6.897386,"marketCap":129659412412.11},"quantilePoints":[{"date":"2020-05-01","current":33.287209,"twenty":10.936939,"median":22.288206,"eighty":27.915788,"marketCap":122748871163.92},{"date":"2020-05-08","current":33.429348,"twenty":10.947749,"median":22.313398,"eighty":28.361828,"marketCap":121627238914.58},{"date":"2020-05-15","current":32.595691,"twenty":10.949613,"median":22.330456,"eighty":28.489712,"marketCap":118247569927.49},{"date":"2020-05-22","current":32.461152,"twenty":10.950809,"median":22.368981,"eighty":28.664689,"marketCap":118529173787.58},{"date":"2020-05-29","current":32.711543,"twenty":10.957417,"median":22.45326,"eighty":28.739014,"marketCap":121900047291.83},{"date":"2020-06-05","current":33.320704,"twenty":10.961705,"median":22.504413,"eighty":28.869762,"marketCap":126404479866.46},{"date":"2020-06-12","current":33.26848,"twenty":10.97427,"median":22.552737,"eighty":29.165734,"marketCap":125312894610.63},{"date":"2020-06-19","current":35.174448,"twenty":10.980961,"median":22.560851,"eighty":29.253683,"marketCap":131987852645.25},{"date":"2020-06-26","current":34.045816,"twenty":10.987268,"median":22.616571,"eighty":29.711727,"marketCap":127924643785.45},{"date":"2020-07-02","current":34.367214,"twenty":10.994274,"median":22.648355,"eighty":29.771242,"marketCap":129509727296.23},{"date":"2020-07-10","current":33.233448,"twenty":10.9995,"median":22.663506,"eighty":32.384166,"marketCap":126030678803.03},{"date":"2020-07-17","current":34.840553,"twenty":11.002375,"median":22.680357,"eighty":32.642032,"marketCap":133469182626.29},{"date":"2020-07-24","current":33.192336,"twenty":11.004309,"median":22.714228,"eighty":32.855777,"marketCap":129403011819.03},{"date":"2020-07-31","current":10.079688,"twenty":10.9995,"median":22.705861,"eighty":32.972702,"marketCap":131609513547.85},{"date":"2020-08-07","current":9.946507,"twenty":10.971294,"median":22.66842,"eighty":32.855777,"marketCap":129396034746.58},{"date":"2020-08-14","current":9.727952,"twenty":10.948867,"median":22.658549,"eighty":32.749663,"marketCap":127031956635.12},{"date":"2020-08-21","current":9.828123,"twenty":10.929747,"median":22.644775,"eighty":32.720989,"marketCap":127780651499.59},{"date":"2020-08-28","current":9.679005,"twenty":10.883242,"median":22.578254,"eighty":32.71485,"marketCap":127069323852.74},{"date":"2020-09-04","current":9.512813,"twenty":10.85502,"median":22.559456,"eighty":32.642032,"marketCap":123841606541.64},{"date":"2020-09-11","current":9.96472,"twenty":10.823199,"median":22.547298,"eighty":32.561309,"marketCap":130185382800.66},{"date":"2020-09-18","current":10.067167,"twenty":10.684765,"median":22.493564,"eighty":32.490302,"marketCap":131820291420.1},{"date":"2020-09-25","current":9.858857,"twenty":10.595525,"median":22.444418,"eighty":32.458162,"marketCap":126422921729.99},{"date":"2020-10-02","current":9.798527,"twenty":10.526117,"median":22.342652,"eighty":32.407337,"marketCap":126679565248.92},{"date":"2020-10-09","current":9.824708,"twenty":10.410161,"median":22.324584,"eighty":32.285505,"marketCap":128128683268.34},{"date":"2020-10-16","current":9.793052,"twenty":10.315413,"median":22.302943,"eighty":31.257628,"marketCap":126623612278.58},{"date":"2020-10-23","current":9.441308,"twenty":10.238589,"median":22.261435,"eighty":29.811136,"marketCap":123347203619.79},{"date":"2020-10-30","current":8.661295,"twenty":10.199611,"median":22.234806,"eighty":29.773341,"marketCap":113280166110.01},{"date":"2020-11-06","current":9.327376,"twenty":10.132097,"median":22.205679,"eighty":29.767042,"marketCap":124442629581.55},{"date":"2020-11-13","current":9.605003,"twenty":10.089923,"median":22.112471,"eighty":29.762798,"marketCap":127479835927.15},{"date":"2020-11-20","current":9.6106,"twenty":10.079688,"median":22.081393,"eighty":29.73408,"marketCap":127917182157.26},{"date":"2020-11-27","current":9.538955,"twenty":10.057978,"median":22.005256,"eighty":29.655002,"marketCap":127995801275.71},{"date":"2020-12-04","current":9.358721,"twenty":10.040076,"median":21.945075,"eighty":29.437865,"marketCap":127467141893.2},{"date":"2020-12-11","current":8.790033,"twenty":10.022546,"median":21.91943,"eighty":29.296005,"marketCap":119489512407.95},{"date":"2020-12-18","current":8.844887,"twenty":9.993694,"median":21.901999,"eighty":29.279125,"marketCap":121396802063.1},{"date":"2020-12-24","current":8.769883,"twenty":9.976103,"median":21.881466,"eighty":29.245202,"marketCap":119941986349.01},{"date":"2020-12-31","current":8.810183,"twenty":9.961936,"median":21.873052,"eighty":29.24273,"marketCap":120950078152.91},{"date":"2021-01-08","current":8.820259,"twenty":9.95106,"median":21.862976,"eighty":29.210969,"marketCap":121221849881.21},{"date":"2021-01-15","current":9.126992,"twenty":9.936588,"median":21.828735,"eighty":29.197581,"marketCap":123845036018.62},{"date":"2021-01-22","current":9.119156,"twenty":9.919292,"median":21.813001,"eighty":29.173346,"marketCap":124582207014},{"date":"2021-01-29","current":8.636715,"twenty":9.906894,"median":21.809329,"eighty":29.059102,"marketCap":117661873131.83},{"date":"2021-02-05","current":8.176599,"twenty":9.88162,"median":21.779975,"eighty":28.982923,"marketCap":120922774999.4},{"date":"2021-02-12","current":7.987538,"twenty":9.856239,"median":21.763827,"eighty":28.950951,"marketCap":119014418424.43},{"date":"2021-02-19","current":7.870014,"twenty":9.848372,"median":21.763595,"eighty":28.901957,"marketCap":117391358460.33},{"date":"2021-02-26","current":7.746359,"twenty":9.840411,"median":21.746147,"eighty":28.832667,"marketCap":115225330598.91},{"date":"2021-03-05","current":7.860937,"twenty":9.827943,"median":21.729717,"eighty":28.787173,"marketCap":115132662522.04},{"date":"2021-03-12","current":8.118972,"twenty":9.808685,"median":21.685029,"eighty":28.757776,"marketCap":119210132761.26},{"date":"2021-03-19","current":8.502978,"twenty":9.798186,"median":21.612115,"eighty":28.742096,"marketCap":124417528040.94},{"date":"2021-03-26","current":8.489771,"twenty":9.792219,"median":21.598158,"eighty":28.727957,"marketCap":123096173961.55},{"date":"2021-04-01","current":8.553964,"twenty":9.788159,"median":21.54258,"eighty":28.711437,"marketCap":123735063715.73},{"date":"2021-04-09","current":8.641332,"twenty":9.782356,"median":21.526019,"eighty":28.694903,"marketCap":126246626546.64},{"date":"2021-04-16","current":8.636253,"twenty":9.769654,"median":21.512492,"eighty":28.66049,"marketCap":127185060180.88},{"date":"2021-04-23","current":8.669778,"twenty":9.761091,"median":21.479045,"eighty":28.625112,"marketCap":128556561372.57},{"date":"2021-04-30","current":8.936356,"twenty":9.755206,"median":21.457669,"eighty":28.539275,"marketCap":131116008424.15},{"date":"2021-05-07","current":8.761308,"twenty":9.751942,"median":21.433287,"eighty":28.492512,"marketCap":129875631253.04},{"date":"2021-05-14","current":8.892563,"twenty":9.741584,"median":21.426198,"eighty":28.475014,"marketCap":131645337996.12},{"date":"2021-05-21","current":9.047404,"twenty":9.729833,"median":21.41999,"eighty":28.415141,"marketCap":134492606805.61},{"date":"2021-05-28","current":9.019717,"twenty":9.710422,"median":21.40835,"eighty":28.40452,"marketCap":134081034734.92},{"date":"2021-06-04","current":8.826935,"twenty":9.707463,"median":21.392314,"eighty":28.379325,"marketCap":130991765454.43},{"date":"2021-06-11","current":9.116284,"twenty":9.694395,"median":21.363939,"eighty":28.361828,"marketCap":134500207706.54},{"date":"2021-06-18","current":9.021943,"twenty":9.679005,"median":21.290156,"eighty":28.230746,"marketCap":130457184786.01},{"date":"2021-06-25","current":9.04963,"twenty":9.672117,"median":21.229467,"eighty":28.073267,"marketCap":131826509965.36},{"date":"2021-07-02","current":9.013739,"twenty":9.660792,"median":21.196129,"eighty":27.996278,"marketCap":130199639608.01},{"date":"2021-07-09","current":8.944008,"twenty":9.658829,"median":21.16444,"eighty":27.931886,"marketCap":129422313900.82},{"date":"2021-07-16","current":9.010663,"twenty":9.638085,"median":21.140332,"eighty":27.848598,"marketCap":129770992211.6},{"date":"2021-07-23","current":9.031172,"twenty":9.62122,"median":21.117164,"eighty":27.80391,"marketCap":129576758627.22},{"date":"2021-07-30","current":18.87536,"twenty":9.610467,"median":21.085355,"eighty":27.796937,"marketCap":129351074870.7},{"date":"2021-08-06","current":18.73975,"twenty":9.613461,"median":21.013453,"eighty":27.749237,"marketCap":127349176618.04},{"date":"2021-08-13","current":19.000477,"twenty":9.62122,"median":20.964049,"eighty":27.709316,"marketCap":129532398703.09},{"date":"2021-08-20","current":19.713131,"twenty":9.626758,"median":20.922915,"eighty":27.702194,"marketCap":133040601577.1},{"date":"2021-08-27","current":19.159086,"twenty":9.631579,"median":20.849323,"eighty":27.682689,"marketCap":130505881690.84},{"date":"2021-09-03","current":19.087386,"twenty":9.636484,"median":20.812207,"eighty":27.640133,"marketCap":131037228600.12},{"date":"2021-09-10","current":17.788527,"twenty":9.637931,"median":20.810313,"eighty":27.621196,"marketCap":121557039339.96},{"date":"2021-09-17","current":17.718998,"twenty":9.644258,"median":20.781658,"eighty":27.597623,"marketCap":120158061709.12},{"date":"2021-09-24","current":17.821119,"twenty":9.653374,"median":20.756596,"eighty":27.571856,"marketCap":120553399377.05},{"date":"2021-10-01","current":17.949313,"twenty":9.657986,"median":20.686673,"eighty":27.533829,"marketCap":120210038226.29},{"date":"2021-10-08","current":18.316512,"twenty":9.65882,"median":20.60166,"eighty":27.49647,"marketCap":122456300914.25},{"date":"2021-10-15","current":18.21668,"twenty":9.659965,"median":20.367209,"eighty":27.481537,"marketCap":122085570969.84},{"date":"2021-10-22","current":18.492625,"twenty":9.660762,"median":19.534967,"eighty":27.418547,"marketCap":124266480579.27},{"date":"2021-10-29","current":17.57188,"twenty":9.660792,"median":19.400258,"eighty":27.363912,"marketCap":125449567069.84},{"date":"2021-11-05","current":17.984594,"twenty":9.662246,"median":19.19059,"eighty":27.343794,"marketCap":128307008370.7},{"date":"2021-11-12","current":18.139856,"twenty":9.664147,"median":19.148222,"eighty":27.315537,"marketCap":128214619445.91},{"date":"2021-11-19","current":18.074795,"twenty":9.669177,"median":19.129754,"eighty":27.3008,"marketCap":126337351612.14},{"date":"2021-11-26","current":17.283895,"twenty":9.672117,"median":19.062399,"eighty":27.290992,"marketCap":120754520924.52},{"date":"2021-12-03","current":17.031784,"twenty":9.672185,"median":18.974404,"eighty":27.274231,"marketCap":118697631154.76},{"date":"2021-12-10","current":17.593219,"twenty":9.673996,"median":18.883829,"eighty":27.261649,"marketCap":122887806332.16},{"date":"2021-12-17","current":17.666414,"twenty":9.676585,"median":18.822313,"eighty":27.226753,"marketCap":122981663791.86},{"date":"2021-12-23","current":17.924629,"twenty":9.677102,"median":18.797147,"eighty":27.187184,"marketCap":125231028798.23},{"date":"2021-12-31","current":18.010023,"twenty":9.680432,"median":18.68789,"eighty":27.152672,"marketCap":126457276638.23},{"date":"2022-01-07","current":18.01409,"twenty":9.687791,"median":18.583882,"eighty":27.099359,"marketCap":126127227506.24},{"date":"2022-01-14","current":18.425049,"twenty":9.694395,"median":18.458837,"eighty":27.042911,"marketCap":129932901404.91},{"date":"2022-01-21","current":18.490113,"twenty":9.694395,"median":18.493429,"eighty":27.028616,"marketCap":129474826588.41},{"date":"2022-01-28","current":19.165142,"twenty":9.694395,"median":18.494232,"eighty":27.028595,"marketCap":132074546389.11},{"date":"2022-02-04","current":18.213402,"twenty":9.69608,"median":18.572578,"eighty":27.025402,"marketCap":129696764676.74},{"date":"2022-02-11","current":18.927495,"twenty":9.697119,"median":18.616113,"eighty":27.010232,"marketCap":134335997389.37},{"date":"2022-02-18","current":18.766118,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":132345369395.97},{"date":"2022-02-25","current":18.833821,"twenty":9.697119,"median":18.575534,"eighty":27.010232,"marketCap":132044689275.57},{"date":"2022-03-04","current":17.617959,"twenty":9.697119,"median":18.491369,"eighty":27.010232,"marketCap":119664437682.82},{"date":"2022-03-11","current":18.783661,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127973204254.43},{"date":"2022-03-18","current":18.717451,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":128848117335.18},{"date":"2022-03-25","current":18.683343,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127751282161.3},{"date":"2022-04-01","current":18.889374,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":129744565958.06},{"date":"2022-04-08","current":20.960102,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":141869390625.41},{"date":"2022-04-14","current":20.695242,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":139183497682.91},{"date":"2022-04-22","current":20.346108,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":136481434838.85},{"date":"2022-04-29","current":18.952765,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":133142723720.1},{"date":"2022-05-06","current":18.179144,"twenty":9.697119,"median":18.493429,"eighty":27.010232,"marketCap":128384549744.68},{"date":"2022-05-13","current":18.692394,"twenty":9.697119,"median":18.527753,"eighty":27.010232,"marketCap":129700736023.73},{"date":"2022-05-20","current":19.16256,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":134758546837.22},{"date":"2022-05-27","current":19.177546,"twenty":9.697119,"median":18.665261,"eighty":27.010232,"marketCap":136958987699.81},{"date":"2022-06-03","current":18.744225,"twenty":9.697119,"median":18.681313,"eighty":27.010232,"marketCap":133921762001.07},{"date":"2022-06-10","current":18.146643,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":127291929717.98},{"date":"2022-06-17","current":17.640852,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":123044805550.91},{"date":"2022-06-24","current":18.83789,"twenty":9.696859,"median":18.692394,"eighty":27.014025,"marketCap":132461365342.83},{"date":"2022-07-01","current":18.293193,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126838383992.09},{"date":"2022-07-08","current":18.63272,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126418025181.68},{"date":"2022-07-15","current":18.795918,"twenty":9.696859,"median":18.717451,"eighty":27.014025,"marketCap":126431471445.01},{"date":"2022-07-22","current":18.263208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124455681540.58},{"date":"2022-07-29","current":18.321107,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124140260314.16},{"date":"2022-08-05","current":18.377647,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123992191551.9},{"date":"2022-08-12","current":16.132936,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109885258896.75},{"date":"2022-08-19","current":15.415581,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102816971778.11},{"date":"2022-08-26","current":15.459,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102642813930.03},{"date":"2022-09-02","current":15.37405,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102457677511.04},{"date":"2022-09-09","current":15.328743,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102237792167.67},{"date":"2022-09-16","current":15.453336,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102882856127.48},{"date":"2022-09-23","current":14.877565,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96093011237.72},{"date":"2022-09-30","current":14.800166,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96408611153.17},{"date":"2022-10-07","current":15.132414,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":98274151179.98},{"date":"2022-10-14","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":99690906745.93},{"date":"2022-10-21","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":100326441165.16},{"date":"2022-10-28","current":16.846401,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":107356651323.46},{"date":"2022-11-04","current":17.17473,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109112652999.6},{"date":"2022-11-11","current":16.109615,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":106637600025.82},{"date":"2022-11-18","current":16.83559,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":111812739546.11},{"date":"2022-11-25","current":17.129097,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":114152420880.73},{"date":"2022-12-02","current":16.782758,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":112782528627.45},{"date":"2022-12-09","current":17.361946,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":117264953276.43},{"date":"2022-12-16","current":17.144751,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":116510134592.3},{"date":"2022-12-23","current":17.802208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121183588329.26},{"date":"2022-12-30","current":17.579142,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":120406882967.83},{"date":"2023-01-06","current":17.829602,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121279894677.35},{"date":"2023-01-13","current":17.841342,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123710007946.55},{"date":"2023-01-20","current":17.659092,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":122645342505.42},{"date":"2023-01-27","current":17.429425,"twenty":9.703429,"median":18.719457,"eighty":27.014025,"marketCap":121260511615.28},{"date":"2023-02-03","current":12.687149,"twenty":9.709538,"median":18.719457,"eighty":27.014025,"marketCap":115251355422.68},{"date":"2023-02-10","current":13.217643,"twenty":9.726396,"median":18.719457,"eighty":27.014025,"marketCap":118159855219.99},{"date":"2023-02-17","current":13.277249,"twenty":9.741642,"median":18.719457,"eighty":27.014025,"marketCap":118515515804.01},{"date":"2023-02-24","current":13.411211,"twenty":9.752083,"median":18.719457,"eighty":27.014025,"marketCap":118448244308.93},{"date":"2023-03-03","current":13.302322,"twenty":9.756767,"median":18.719457,"eighty":27.014025,"marketCap":118034490740.94},{"date":"2023-03-10","current":13.357512,"twenty":9.764714,"median":18.719457,"eighty":27.014025,"marketCap":119257397037.12},{"date":"2023-03-17","current":13.394803,"twenty":9.773462,"median":18.719457,"eighty":27.014025,"marketCap":119526591543.55},{"date":"2023-03-24","current":14.48369,"twenty":9.785178,"median":18.719457,"eighty":27.014025,"marketCap":130424881067.13},{"date":"2023-03-31","current":14.952061,"twenty":9.790694,"median":18.718645,"eighty":27.010232,"marketCap":135988374469.8},{"date":"2023-04-06","current":15.280218,"twenty":9.798413,"median":18.718645,"eighty":27.010232,"marketCap":139686260171.45},{"date":"2023-04-14","current":15.221476,"twenty":9.80991,"median":18.730688,"eighty":27.025402,"marketCap":140825574178.82},{"date":"2023-04-19","current":15.209543,"twenty":9.82744,"median":18.731112,"eighty":27.026041,"marketCap":139558349488.11},{"date":"2023-04-27","current":15.21474,"twenty":9.850092,"median":18.73173,"eighty":27.027318,"marketCap":140140612943.9},{"date":"2023-05-05","current":15.175888,"twenty":9.902113,"median":18.731826,"eighty":27.028595,"marketCap":139552044885.56},{"date":"2023-05-12","current":14.838181,"twenty":9.939677,"median":18.731826,"eighty":27.028595,"marketCap":135403671391.13},{"date":"2023-05-19","current":15.184854,"twenty":9.959028,"median":18.731826,"eighty":27.028595,"marketCap":136642429723.27},{"date":"2023-05-26","current":14.853124,"twenty":9.978835,"median":18.733652,"eighty":27.028599,"marketCap":133126940240.24},{"date":"2023-06-02","current":14.192653,"twenty":10.040758,"median":18.733652,"eighty":27.028599,"marketCap":127343787455.44},{"date":"2023-06-09","current":14.256612,"twenty":10.09699,"median":18.733652,"eighty":27.028599,"marketCap":128372490395.43},{"date":"2023-06-16","current":14.295467,"twenty":10.208772,"median":18.72486,"eighty":27.028599,"marketCap":130508209942.1},{"date":"2023-06-23","current":14.734821,"twenty":10.181908,"median":18.697387,"eighty":27.028603,"marketCap":134961533039.24},{"date":"2023-06-30","current":14.675045,"twenty":10.181908,"median":18.683343,"eighty":27.028603,"marketCap":133521342889.49},{"date":"2023-07-07","current":14.039924,"twenty":10.181908,"median":18.651241,"eighty":27.028603,"marketCap":127451273212.04},{"date":"2023-07-14","current":14.002564,"twenty":10.181908,"median":18.628706,"eighty":27.028603,"marketCap":130982117535.26},{"date":"2023-07-21","current":14.736316,"twenty":10.181908,"median":18.609955,"eighty":27.028603,"marketCap":137261916493.54},{"date":"2023-07-28","current":14.230057,"twenty":10.155044,"median":18.575133,"eighty":27.028608,"marketCap":130696325708.32},{"date":"2023-08-04","current":13.64955,"twenty":10.155044,"median":18.53333,"eighty":27.028608,"marketCap":128783719369.32},{"date":"2023-08-11","current":14.107345,"twenty":10.155044,"median":18.465688,"eighty":27.028608,"marketCap":133909438393.92},{"date":"2023-08-18","current":14.257236,"twenty":10.155044,"median":18.417461,"eighty":27.028608,"marketCap":133639295738.06},{"date":"2023-08-25","current":14.360528,"twenty":10.155044,"median":18.371061,"eighty":27.028608,"marketCap":134024340566.45},{"date":"2023-09-01","current":14.34598,"twenty":10.155044,"median":18.34457,"eighty":27.028608,"marketCap":134077344689.8},{"date":"2023-09-08","current":14.597664,"twenty":10.155044,"median":18.325923,"eighty":27.028608,"marketCap":134604678073.84},{"date":"2023-09-15","current":14.95555,"twenty":10.155044,"median":18.296091,"eighty":27.016307,"marketCap":137463437822.93},{"date":"2023-09-22","current":14.853801,"twenty":10.12818,"median":18.276078,"eighty":27.020855,"marketCap":136484543397.31},{"date":"2023-09-29","current":14.763602,"twenty":10.12818,"median":18.246983,"eighty":26.983029,"marketCap":134423031209.85},{"date":"2023-10-06","current":14.868349,"twenty":10.12818,"median":18.218159,"eighty":26.938973,"marketCap":134892153493.37},{"date":"2023-10-13","current":15.040019,"twenty":10.12818,"median":18.16832,"eighty":26.598464,"marketCap":136737545848.28},{"date":"2023-10-20","current":14.380784,"twenty":10.12818,"median":18.144978,"eighty":26.402781,"marketCap":131062102932.84},{"date":"2023-10-27","current":11.85036,"twenty":10.092665,"median":18.111628,"eighty":26.025777,"marketCap":107534279335.51},{"date":"2023-11-03","current":11.80423,"twenty":10.092665,"median":18.07332,"eighty":25.817137,"marketCap":113606320100.85},{"date":"2023-11-10","current":11.775378,"twenty":10.092665,"median":18.059836,"eighty":25.817137,"marketCap":114360557197.64},{"date":"2023-11-17","current":11.879108,"twenty":10.092665,"median":18.023837,"eighty":25.817137,"marketCap":116984566837.93},{"date":"2023-11-24","current":11.946878,"twenty":10.092665,"median":18.009006,"eighty":25.817137,"marketCap":118113843833.15},{"date":"2023-12-01","current":11.863894,"twenty":10.092665,"median":17.972228,"eighty":25.817137,"marketCap":117306211282.58},{"date":"2023-12-08","current":11.912301,"twenty":10.09699,"median":17.952065,"eighty":25.812238,"marketCap":116514105188.26},{"date":"2023-12-15","current":12.129442,"twenty":10.09699,"median":17.934507,"eighty":25.812238,"marketCap":120907663627.27},{"date":"2023-12-22","current":12.356264,"twenty":10.09699,"median":17.886813,"eighty":25.812238,"marketCap":123141571763.22},{"date":"2023-12-29","current":12.414352,"twenty":10.092665,"median":17.852857,"eighty":25.817137,"marketCap":124666059594.59},{"date":"2024-01-05","current":12.928851,"twenty":10.088339,"median":17.827036,"eighty":25.822036,"marketCap":128452561703.01},{"date":"2024-01-12","current":13.228975,"twenty":10.088339,"median":17.806558,"eighty":25.822036,"marketCap":131304891825.05},{"date":"2024-01-19","current":13.006481,"twenty":10.084014,"median":17.776767,"eighty":25.826935,"marketCap":128114681751.41},{"date":"2024-01-26","current":12.735372,"twenty":10.088339,"median":17.745072,"eighty":25.822036,"marketCap":125131555256.31},{"date":"2024-02-02","current":20.334039,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":119118906599.05},{"date":"2024-02-09","current":20.085581,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116751493787.94},{"date":"2024-02-16","current":20.076293,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116634730314.15},{"date":"2024-02-23","current":20.830953,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":121673497945.92},{"date":"2024-03-01","current":20.187328,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":117837605321.59},{"date":"2024-03-08","current":20.275189,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119656853104.92},{"date":"2024-03-15","current":20.393108,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119946394721.71},{"date":"2024-03-22","current":20.497155,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":120191807946.57},{"date":"2024-03-28","current":21.03126,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122670991700.15},{"date":"2024-04-05","current":20.194264,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":118454296559.85},{"date":"2024-04-12","current":19.993107,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115628981743.6},{"date":"2024-04-19","current":20.090217,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115682634323.95},{"date":"2024-04-26","current":25.102236,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122028864510.98},{"date":"2024-05-03","current":25.121496,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":121965711156.52},{"date":"2024-05-10","current":25.955211,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":126909542740.01},{"date":"2024-05-17","current":24.564329,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121166222484.78},{"date":"2024-05-24","current":24.660746,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121128331641.95},{"date":"2024-05-31","current":24.726861,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121676961247.02},{"date":"2024-06-07","current":25.104265,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":123964258787.81},{"date":"2024-06-14","current":23.809521,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":116305279179.76},{"date":"2024-06-21","current":24.137339,"twenty":10.088339,"median":17.71521,"eighty":25.90586,"marketCap":117375957434.63},{"date":"2024-06-28","current":24.776447,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":120367749389.79},{"date":"2024-07-05","current":25.051924,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":122903385527.57},{"date":"2024-07-12","current":26.005076,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":128286809560.82},{"date":"2024-07-15","current":25.462386,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":126116902211.31},{"date":"2024-08-02","current":28.58221,"twenty":10.045539,"median":17.667431,"eighty":25.970775,"marketCap":129963975586.71},{"date":"2024-08-09","current":28.611937,"twenty":10.045539,"median":17.667431,"eighty":26.395222,"marketCap":131603672136.16},{"date":"2024-08-16","current":29.365903,"twenty":10.045539,"median":17.667431,"eighty":26.965608,"marketCap":135991482271.53},{"date":"2024-08-23","current":29.827758,"twenty":10.045539,"median":17.667431,"eighty":27.30154,"marketCap":139679917173.16},{"date":"2024-08-30","current":30.083408,"twenty":10.045539,"median":17.667431,"eighty":27.737312,"marketCap":140486982478.95},{"date":"2024-09-06","current":31.076279,"twenty":10.045539,"median":17.667431,"eighty":27.755808,"marketCap":145252320920.18},{"date":"2024-09-13","current":30.737395,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":143002491189.58},{"date":"2024-09-20","current":30.78296,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144554419337.27},{"date":"2024-09-27","current":30.616469,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144270741555.83},{"date":"2024-10-04","current":30.241865,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":140433638887.54},{"date":"2024-10-11","current":29.775602,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":137150593697.15},{"date":"2024-10-18","current":29.977793,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":136855848164.59},{"date":"2024-10-25","current":29.757762,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":135513851100.67},{"date":"2024-10-31","current":27.016329,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":132177608883.82},{"date":"2024-11-08","current":26.635368,"twenty":10.044628,"median":17.666414,"eighty":26.885017,"marketCap":129456333845.32},{"date":"2024-11-15","current":25.402919,"twenty":10.044628,"median":17.666414,"eighty":26.404422,"marketCap":121101937530.68},{"date":"2024-11-22","current":25.92038,"twenty":10.044628,"median":17.666414,"eighty":25.927346,"marketCap":122518864801.22},{"date":"2024-11-29","current":25.619919,"twenty":10.044628,"median":17.666414,"eighty":25.699083,"marketCap":121788536423.67},{"date":"2024-12-06","current":25.644957,"twenty":10.044628,"median":17.666414,"eighty":25.611269,"marketCap":122139495847.16},{"date":"2024-12-13","current":24.807559,"twenty":10.044628,"median":17.666414,"eighty":25.528111,"marketCap":117246552266.62},{"date":"2024-12-20","current":25.394572,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":118799775303.16},{"date":"2024-12-27","current":25.950983,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":121782054794.83},{"date":"2025-01-03","current":25.836919,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":119394068299.66},{"date":"2025-01-10","current":26.476134,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":122813940759.73},{"date":"2025-01-17","current":27.190583,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":126128028900.56},{"date":"2025-01-24","current":27.736112,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":130118603784.49},{"date":"2025-01-31","current":22.679241,"twenty":10.043718,"median":17.662753,"eighty":25.458421,"marketCap":135796476672.57},{"date":"2025-02-07","current":22.453317,"twenty":10.043718,"median":17.662753,"eighty":25.395685,"marketCap":133815994648.27},{"date":"2025-02-14","current":22.527177,"twenty":10.043718,"median":17.662753,"eighty":25.302609,"marketCap":135139535422.45},{"date":"2025-02-21","current":23.475533,"twenty":10.043718,"median":17.662753,"eighty":25.274251,"marketCap":136588490535.79},{"date":"2025-02-28","current":23.529645,"twenty":10.043718,"median":17.662753,"eighty":25.156716,"marketCap":136134051560.87},{"date":"2025-03-07","current":24.715596,"twenty":10.042807,"median":17.659092,"eighty":25.048936,"marketCap":148818188841.24},{"date":"2025-03-14","current":23.949012,"twenty":10.042807,"median":17.659092,"eighty":24.864048,"marketCap":144656712656.17},{"date":"2025-03-21","current":23.863334,"twenty":10.042807,"median":17.659092,"eighty":24.801725,"marketCap":143967164905.6},{"date":"2025-03-28","current":22.763528,"twenty":10.042807,"median":17.659092,"eighty":24.715596,"marketCap":136620485714.59},{"date":"2025-04-04","current":21.134417,"twenty":10.042807,"median":17.659092,"eighty":24.626125,"marketCap":130072347841.49},{"date":"2025-04-11","current":19.729859,"twenty":10.043718,"median":17.662753,"eighty":24.453364,"marketCap":122690991838.72},{"date":"2025-04-17","current":19.969823,"twenty":10.043718,"median":17.662753,"eighty":24.305248,"marketCap":126259056108.71},{"date":"2025-04-25","current":17.94759,"twenty":10.042807,"median":17.659092,"eighty":24.198495,"marketCap":128365926735.55},{"date":"2025-04-28","current":18.091389,"twenty":10.042807,"median":17.659092,"eighty":24.157724,"marketCap":129659412412.11}],"updateTime":1745994819284}}}